QCM
OPRX icon

Quantinno Capital Management’s OptimizeRx OPRX Stock Holding History

Quantinno Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
99,124
+50,102
+102% +$288K ﹤0.01% 2917
2026
Q1 		$308K Buy
49,022
+31,518
+180% +$293K ﹤0.01% 3017
2025
Q4 		$215K Buy
17,504
+3,157
+22% +$51.6K ﹤0.01% 3026
2025
Q3 		$294K Buy
14,347
+1,852
+15% +$29.4K ﹤0.01% 2472
2025
Q2 		$169K Buy
12,495
+476
+4% +$5.21K ﹤0.01% 2405
2025
Q1 		$104K Buy
+12,019
New +$73.5K ﹤0.01% 2023

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Quantinno Capital Management's OPRX Position: Q2 2026 in Review

Quantinno Capital Management increased its OptimizeRx (OPRX) stake by 102% in Q2 2026, buying an estimated $288K and bringing the position to 99,124 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

Quantinno Capital Management first reported a position in OPRX in Q1 2025 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Quantinno Capital Management held 99,124 shares of OptimizeRx worth $567K as of Q2 2026.
  • Quantinno Capital Management bought 50,102 OptimizeRx shares in Q2 2026, an estimated $288K.
  • OptimizeRx made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2917 holding.
  • Quantinno Capital Management first reported a position in OptimizeRx in Q1 2025 and has held it in 6 quarters since.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.